These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19432998

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium.
    Jin D, He P, You X, Zhu X, Dai L, He Q, Liu C, Hui N, Sha J, Ni X.
    Reprod Sci; 2007 Sep; 14(6):568-77. PubMed ID: 17959885
    [Abstract] [Full Text] [Related]

  • 3. Corticotropin-releasing hormone receptor subtype 1 is significantly up-regulated at the time of labor in the human myometrium.
    Stevens MY, Challis JR, Lye SJ.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4107-15. PubMed ID: 9814500
    [Abstract] [Full Text] [Related]

  • 4. Identification of a novel corticotropin-releasing hormone type 1beta-like receptor variant lacking Exon 13 in human pregnant myometrium regulated by estradiol-17beta and progesterone.
    Karteris E, Markovic D, Chen J, Hillhouse EW, Grammatopoulos DK.
    Endocrinology; 2010 Oct; 151(10):4959-68. PubMed ID: 20702571
    [Abstract] [Full Text] [Related]

  • 5. The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1beta.
    Markovic D, Vatish M, Gu M, Slater D, Newton R, Lehnert H, Grammatopoulos DK.
    Endocrinology; 2007 Jul; 148(7):3205-13. PubMed ID: 17431005
    [Abstract] [Full Text] [Related]

  • 6. Levels of corticotrophin-releasing hormone receptor subtype 1 mRNA in pregnancy and during labour in human myometrium measured by quantitative competitive PCR.
    Rodríguez-Liñares B, Phaneuf S, López Bernal A, Linton EA.
    J Mol Endocrinol; 1998 Oct; 21(2):201-8. PubMed ID: 9801463
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CRH acts on CRH-R1 and -R2 to differentially modulate the expression of large-conductance calcium-activated potassium channels in human pregnant myometrium.
    Xu C, Gao L, You X, Dai L, Li Y, Gu H, Slater DM, Olson DM, Ni X.
    Endocrinology; 2011 Nov; 152(11):4406-17. PubMed ID: 21878514
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
    Grammatopoulos DK, Randeva HS, Levine MA, Katsanou ES, Hillhouse EW.
    Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
    [Abstract] [Full Text] [Related]

  • 11. Expression of corticotrophin-releasing hormone receptor mRNA and protein in the human myometrium.
    Rodríguez-Liñares B, Linton EA, Phaneuf S.
    J Endocrinol; 1998 Jan; 156(1):15-21. PubMed ID: 9496229
    [Abstract] [Full Text] [Related]

  • 12. Corticotrophin releasing hormone: its potential for a role in human myometrium.
    Linton EA, Woodman JR, Asboth G, Glynn BP, Plested CP, Bernal AL.
    Exp Physiol; 2001 Mar; 86(2):273-81. PubMed ID: 11429644
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Corticotropin-releasing hormone acts on CRH-R1 to inhibit the spontaneous contractility of non-labouring human myometrium at term.
    Zhang LM, Wang YK, Hui N, Sha JY, Chen X, Guan R, Dai L, Gao L, Yuan WJ, Ni X.
    Life Sci; 2008 Oct 24; 83(17-18):620-4. PubMed ID: 18805429
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.
    Grammatopoulos DK, Dai Y, Randeva HS, Levine MA, Karteris E, Easton AJ, Hillhouse EW.
    Mol Endocrinol; 1999 Dec 24; 13(12):2189-202. PubMed ID: 10598591
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d.
    Markovic D, Lehnert H, Levine MA, Grammatopoulos DK.
    Mol Endocrinol; 2008 Nov 24; 22(11):2505-19. PubMed ID: 18772229
    [Abstract] [Full Text] [Related]

  • 20. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility.
    Karteris E, Hillhouse EW, Grammatopoulos D.
    Endocrinology; 2004 Feb 24; 145(2):890-900. PubMed ID: 14592950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.